Merck & Co., Inc – Company Snapshot & SWOT Analysis Market Report; Launched via MarketResearchReports.com

As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023.

 

Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company’s operations are principally managed on a products basis and include four operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments.

 

The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities.

 

Merck reported revenue of USD 42.294 billion for the FY 2018 which saw an increase of 5.41% compared to FY 2017. This revenue is expected to increase by 5.68% and reach USD 44.700 billion by FY 2019.

 

Merck & Co., Inc. registered highest revenue from oncology (Keytruda, Emend, Temodar, Alliance revenue – Lynparza and Alliance revenue – Lenvima) at USD 8.243 billion which accounted for 21.87% of its total pharmaceuticals sales in FY 2018.

 

Looking into 2019, Merck said it sees non-GAAP earnings of between $4.57 and $4.72 per share on worldwide sales of between $43.2 billion and $44.7 billion.

 

Spanning over 29 pages and 13 exhibits, “Merck & Co., Inc – Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.

 

Scope of the Merck & Co., Inc – Company Snapshot & SWOT Analysis Report

– This report provides detailed information about Merck & Co., Inc including value chain analysis, financial performance, business strategy and SWOT analysis.

– The report identifies the growth drivers and inhibitors for global pharmaceutical market.

– This report provides information about current and future trends for global pharmaceutical market.

 

For more details visit: https://www.marketresearchreports.com/navadhi/merck-co-inc-company-snapshot-swot-analysis

 

Browse more on   Pharma andHealthcare Market Research Reports

 

Read our Interactive Market Research Blog

 

About MarketResearchReports.com

MarketResearchReports.com is world’s largest store offering quality marketresearch, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

 

About NAVADHI Market Research Pvt Ltd.

NAVADHI is a market research company that helps global firms differentiate themselves, break market entry barriers, track their investments, develop business strategies and plan for future by providing actionable market research intelligence that helps them succeed.

 

Press Contact:
Mr. Sudeep Chakravarty
Director – Operations
MarketResearchReports.com

USA: +1-302-703-9904

 

Contact us for your market research requirements: https://www.marketresearchreports.com/contact